GlassScriptPhysician profile
Phillip J Dabrowski
NPI 1376866095
$673.45
in general payments reported to CMS, 2019-2025
13 companies · $81.89 in 2025
The $81.89 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91.33 · 2020: $10.52 · 2021: $44.88 · 2022: $98.34 · 2023: $115 · 2024: $231 · 2025: $81.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $428.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $190.22 | 2019-2025 | Aequalis Ascend Flex, Aequalis Perform |
| Paragon 28, INC. | $136.50 | 2024 | Trauma |
| Smith+Nephew, INC. | $85.18 | 2019-2025 | Pico 7, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Dynasplint Systems INC. | $53.64 | 2019 | |
| Medwest Associates | $42.59 | 2023 | |
| Ermi LLC | $34.34 | 2024 | |
| Lightbody Medical Technologies INC | $29.60 | 2024 | |
| Orthofix Medical, INC. | $26.04 | 2020-2024 | Physio-Stim |
| Davol INC. | $15.99 | 2025 | Surgiphor |
| Avanos Medical | $15.69 | 2023 | Trivisc Sodium Hyaluronate |
| Merck Sharp & Dohme LLC | $15.20 | 2024 | Gardasil 9, Gardasil |
| Horizon Therapeutics Plc | $15.05 | 2022 | |
| Kci USA, INC. | $13.41 | 2023 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Dabrowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.